Atomoxetine

CHEMBL641 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

255.4 g/mol

LogP

3.7

Phase

4

A selective norepinephrine reuptake inhibitor that increases norepinephrine levels in the prefrontal cortex to improve attention, impulse control, and hyperactivity in ADHD. Unlike stimulants, it is not a controlled substance and does not have abuse potential.

Masse moléculaire

255,3500 g/mol

LogP

3,70

TPSA

21,30 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Psychiatry Non-Small Cell Lung Cancer Parkinson's Disease Schizophrenia Generalized Anxiety Disorder Insomnia Multiple Sclerosis Obesity Type 2 Diabetes Hypertension Major Depressive Disorder Breast Cancer Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CNCC[C@@H](Oc1ccccc1C)c1ccccc1

InChI

InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1

Molecular Formula

C17H21NO

HBD / HBA

1 / 2

Liaisons Rotatives

6

Atomes Lourds

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A selective norepinephrine reuptake inhibitor that increases norepinephrine levels in the prefrontal cortex to improve attention, impulse control, and hyperactivity in ADHD. Unlike stimulants, it is not a controlled substance and does not have abuse potential.

Yes, Atomoxetine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL641. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 54841. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Atomoxetine sur PillFYI

Structure

Données Clés

Formule: C17H21NO
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.